Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance
P Koehler, M Bassetti, A Chakrabarti… - The Lancet Infectious …, 2021 - thelancet.com
Severe acute respiratory syndrome coronavirus 2 causes direct damage to the airway
epithelium, enabling aspergillus invasion. Reports of COVID-19-associated pulmonary …
epithelium, enabling aspergillus invasion. Reports of COVID-19-associated pulmonary …
The natural history, pathobiology, and clinical manifestations of SARS-CoV-2 infections
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiological agent of
coronavirus disease 2019 (COVID-19). SARS-CoV-2, is a positive-sense single-stranded …
coronavirus disease 2019 (COVID-19). SARS-CoV-2, is a positive-sense single-stranded …
Infectious Diseases Society of America Guidelines on the treatment and management of patients with coronavirus disease 2019 (COVID-19)
Background There are many pharmacologic therapies that are being used or considered for
treatment of coronavirus disease 2019 (COVID-19). There is a need for frequently updated …
treatment of coronavirus disease 2019 (COVID-19). There is a need for frequently updated …
An update on COVID-19 pandemic: the epidemiology, pathogenesis, prevention and treatment strategies
Introduction To date, the transmission of Coronavirus Disease-2019 (COVID-19) is still
uncontrollable with the fact that the numbers of confirmed and death cases are still …
uncontrollable with the fact that the numbers of confirmed and death cases are still …
A review: Mechanism of action of antiviral drugs
S Kausar, F Said Khan… - International journal …, 2021 - journals.sagepub.com
Antiviral drugs are a class of medicines particularly used for the treatment of viral infections.
Drugs that combat viral infections are called antiviral drugs. Viruses are among the major …
Drugs that combat viral infections are called antiviral drugs. Viruses are among the major …
Evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as coronavirus disease 2019 (COVID-19) pandemic: A global health emergency
According to data compiled by researchers at Johns Hopkins University in Baltimore,
Maryland, more than two and half million cases of coronavirus disease 2019 (COVID-19) …
Maryland, more than two and half million cases of coronavirus disease 2019 (COVID-19) …
[HTML][HTML] Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19
S Arshad, P Kilgore, ZS Chaudhry, G Jacobsen… - International journal of …, 2020 - Elsevier
Abstract Significance The United States is in an acceleration phase of the COVID-19
pandemic. Currently there is no known effective therapy or vaccine for treatment of SARS …
pandemic. Currently there is no known effective therapy or vaccine for treatment of SARS …
Early short-course corticosteroids in hospitalized patients with COVID-19
Background There is no proven antiviral or immunomodulatory therapy for coronavirus
disease 2019 (COVID-19). The disease progression associated with the proinflammatory …
disease 2019 (COVID-19). The disease progression associated with the proinflammatory …
Antiviral treatment of COVID-19
Currently, there is not any specific effective antiviral treatment for COVID-19. Although most
of the COVID-19 patients have mild or moderate courses, up to 5%-10% can have severe …
of the COVID-19 patients have mild or moderate courses, up to 5%-10% can have severe …
COVID-19, mast cells, cytokine storm, psychological stress, and neuroinflammation
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) is a new pandemic infectious disease that originated in China …
coronavirus 2 (SARS-CoV-2) is a new pandemic infectious disease that originated in China …